EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prostaglandin a in plasma of tumor bearing patients






Periodicum Biologorum 88(1): 25-30

Prostaglandin a in plasma of tumor bearing patients

A highly reproducible method of radioimmunossay was applied to assess prostaglandin A (PGA) content in plasma of patients suffering from Hodgkin's disease and breast cancer. Plasma specimens from patients with Hodgkin's disease were collected prior to splenectomy and plasma specimens from women with breast cancer were collected during adjuvant radiotherapy, that is, in the state of minimal residual disease. Elevated values of PGA were detected n plasma of patients suffering from either Hodgkin's disease (802.9 .+-. 120.4 pgml-1) or breast cancer (1212.0 .+-. 0.235.1 pgml-1) while almost normal ranges were observed in plasma of patients with chronic renal failure maintained on regular haemodialysis.


Accession: 006206728



Related references

Kovacs, C.J.; Harrell, J.P.; Evans, M.J.; Johnke, R.M., 1992: Absence of interleukin 1 alpha radioprotection in tumor-bearing animals: elevated plasma levels of prostaglandin E versus a preexisting primed marrow. Recombinant human interleukin 1 (IL-1) administered as a "priming" agent 24 h prior to hematopoietically lethal doses of total body irradiation (TBI) confers radioprotection to normal C57B1/6 (B6) mice, but not to B6 tumor-bearing animal...

Schaur, R.J.; Fellier, H.; Gleispach, H.; Fink, E.; Kronberger, L., 1979: Tumor host relations. I. Increased plasma cortisol in tumor-bearing humans compared with patients with benign surgical diseases. Plasma cortisol was measured by a protein binding technique in 81 patients with malignant tumors of different extent and various sites and in 82 patients with benign surgical diseases. The mean value of the tumor patients (x +/- s = 165 +/- 69 mic...

Schaur, R.J.; Fellier, H.; Gleispach, H.; Fink, E.; Kronberger, L., 1979: Tumor host relations 1. increased plasma cortisol in tumor bearing humans compared with patients with benign surgical disease. Plasma cortisol was measured by a protein binding technique in 81 patients with malignant tumors of different extent and various sites and in 82 patients with benign surgical diseases. The mean value of the tumor patients (.hivin.x .+-. s = 165 .+...

Malachi, T.; Chaimoff, C.; Feller, N.; Halbrecht, I., 1981: Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients. Prostaglandin E2 and cyclic AMP (cAMP) levels were measured in tumors and plasma of 78 patients with benign and malignant breast tumors. Two groups of malignant tissues were found, one with a high level of PGE2 (M = 55.4 pg/mg) and one with a low...

Stern, R.; Frost, G.I.; Csoka, A.; Wong, T.M., 2001: Method of treating tumor-bearing patients with human plasma hyaluronidase. The invention is based on the discovery of methods for purification of an acid active hyaluronidase found in human plasma (hpHAse), including both biochemical and immunoaffinity purification methods. The method of immunoaffinity purification of th...

Sekiguchi, M.; Odaka, T.; Fujii, G.; Ishibashi, Y., 1970: Immune response in tumor-bearing patients and animals. IV. Immunological competence in lymphoid cells of tumor-bearing mice. Revue Europeenne D'etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research 15(1): 90-95

Wang, W.; Andersson, M.; Lönnroth, C.; Svanberg, E.; Lundholm, K., 2005: Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia. Previous studies in our laboratory have suggested that prostaglandin (PG) E2 is involved in anorexia/cachexia development in MCG 101 tumor-bearing mice. However, the role of COX pathways in the pathogenesis of cancer anorexia/cachexia is not fully...

Takekawa, Y.; Kimura, M.; Sakakibara, M.; Yoshii, R.; Ato, M.; Nemoto, N.; Sakurai, I., 1999: Immunohistochemical study of Sertoli-stromal cell tumor; comparison between the tumor arising from the gonad of a testicular feminization syndrome bearing patient and from ovaries of non-bearing patients. The association of Sertoli-stromal cell tumor with testicular feminization syndrome (TFS) has been elaborated in the past studies. Here, we described immunohistochemical studies on Sertoli cell tumor of the gonad in a TFS patient and compare with...

Silva, J.; Silva, J.M.; García, V.; García, J.M.; Domínguez, G.; Bonilla, Félix., 2002: RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis. Recent studies, however, have suggested that microsatellite unstable cancers with mutations in the proapoptotic gene BAX have a relatively poor prognosis...

Lala, P.K.; Parhar, R.S.; Singh, P., 1986: Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. We have shown earlier that a decline in splenic natural killer (NK) activity during the development of transplanted or spontaneous tumors in mice results from an inactivation of NK lineage cells, mediated by prostaglandins (primarily PGE2) secrete...